# Frovatriptan Succinate (Frovatriptan Succinate)

Source: https://ourhealthnetwork.com/drugs/frovatriptan-succinate
Data: FDA Orange Book and OpenFDA, refreshed periodically

## What is Frovatriptan Succinate?

Frovatriptan Succinate is a selective serotonin receptor agonist. It is prescribed to treat migraine disorders. Across the United States, 162 doctors prescribe Frovatriptan to approximately 18 Medicare patients.

## Brand names

Frovatriptan Succinate

## Indications

Frovatriptan Succinate is primarily prescribed for the treatment of migraine disorders.

## Conditions treated

- [Migraine Disorders](https://ourhealthnetwork.com/conditions/migraine-disorders)

## Mechanism of action

Frovatriptan binds with high affinity to 5-HT 1B/1D receptors. The therapeutic activity of frovatriptan is thought to be due to the agonist effects at the 5-HT 1B/1D receptors on intracranial blood vessels (including the arterio-venous anastomoses) and sensory nerves of the trigeminal system which result in cranial vessel constriction and inhibition of pro-inflammatory neuropeptide release.

## Drug classification

- Established Pharmacologic Class: selective serotonin receptor agonists
- Route of administration: ORAL

## Common side effects

caucasian, chest pain, dizziness, dry mouth, dyspepsia, fatigue, flushing ( 6, headache

## Sources and disclaimers

- FDA Orange Book and OpenFDA dataset
- This information is for educational purposes only and does not constitute medical advice. Always consult a healthcare professional before starting, stopping, or changing any medication.

## Related

- [All drugs](https://ourhealthnetwork.com/drugs)
- [Find specialists who prescribe this drug](https://ourhealthnetwork.com/find-doctors)
- [Methodology](https://ourhealthnetwork.com/methodology)